Andrew M. Hanby

11.7k total citations
128 papers, 7.5k citations indexed

About

Andrew M. Hanby is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Andrew M. Hanby has authored 128 papers receiving a total of 7.5k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Molecular Biology, 48 papers in Oncology and 47 papers in Cancer Research. Recurrent topics in Andrew M. Hanby's work include Breast Cancer Treatment Studies (25 papers), Breast Lesions and Carcinomas (21 papers) and Cancer and Skin Lesions (18 papers). Andrew M. Hanby is often cited by papers focused on Breast Cancer Treatment Studies (25 papers), Breast Lesions and Carcinomas (21 papers) and Cancer and Skin Lesions (18 papers). Andrew M. Hanby collaborates with scholars based in United Kingdom, United States and Canada. Andrew M. Hanby's co-authors include Richard Poulsom, Valerie Speirs, Massimo Pignatelli, Diana M. Barnes, Ian Tomlinson, Nicholas A. Wright, Mark Lansdown, Rebecca Roylance, Cheryl Gillett and Qilong Lu and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Andrew M. Hanby

128 papers receiving 7.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew M. Hanby United Kingdom 49 3.3k 2.6k 2.2k 1.5k 1.2k 128 7.5k
Cheryl Gillett United Kingdom 45 4.2k 1.3× 4.0k 1.5× 2.4k 1.1× 1.3k 0.8× 652 0.6× 123 8.5k
José Palacios Spain 57 5.1k 1.5× 3.6k 1.4× 3.4k 1.5× 1.8k 1.2× 913 0.8× 204 10.4k
James J. Going United Kingdom 45 2.0k 0.6× 2.9k 1.1× 1.5k 0.7× 1.3k 0.9× 1.3k 1.1× 147 6.3k
Hans‐Peter Sinn Germany 47 2.9k 0.9× 3.4k 1.3× 3.3k 1.5× 1.3k 0.9× 661 0.6× 260 8.3k
Tetsunari Oyama Japan 43 2.9k 0.9× 2.8k 1.0× 1.7k 0.8× 900 0.6× 1.3k 1.1× 281 7.2k
Alan Mackay United Kingdom 56 5.5k 1.7× 3.9k 1.5× 3.5k 1.6× 1.6k 1.0× 528 0.4× 134 10.1k
Gamze Karaca United States 28 3.4k 1.0× 4.6k 1.8× 4.3k 1.9× 1.4k 0.9× 767 0.7× 40 9.6k
Shikha Bose United States 43 6.3k 1.9× 2.6k 1.0× 2.1k 0.9× 1.6k 1.0× 1.1k 0.9× 109 10.2k
Rosemary R. Millis United Kingdom 44 1.7k 0.5× 2.5k 0.9× 2.2k 1.0× 1.9k 1.2× 766 0.7× 117 5.9k
Harry Hollema Netherlands 61 3.5k 1.0× 4.0k 1.5× 2.3k 1.0× 2.3k 1.5× 2.0k 1.7× 229 11.9k

Countries citing papers authored by Andrew M. Hanby

Since Specialization
Citations

This map shows the geographic impact of Andrew M. Hanby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew M. Hanby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew M. Hanby more than expected).

Fields of papers citing papers by Andrew M. Hanby

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew M. Hanby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew M. Hanby. The network helps show where Andrew M. Hanby may publish in the future.

Co-authorship network of co-authors of Andrew M. Hanby

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew M. Hanby. A scholar is included among the top collaborators of Andrew M. Hanby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew M. Hanby. Andrew M. Hanby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Molostvov, Guerman, Mariam Gachechiladze, Abeer M. Shaaban, et al.. (2023). Tspan6 stimulates the chemoattractive potential of breast cancer cells for B cells in an EV- and LXR-dependent manner. Cell Reports. 42(3). 112207–112207. 12 indexed citations
2.
Tulotta, Claudia, Diane V. Lefley, Walter M. Gregory, et al.. (2019). Endogenous Production of IL1B by Breast Cancer Cells Drives Metastasis and Colonization of the Bone Microenvironment. Clinical Cancer Research. 25(9). 2769–2782. 136 indexed citations
3.
Bell, Sandra, Andrew M. Hanby, Abeer M. Shaaban, et al.. (2019). Genomic and Expression Analyses Define MUC17 and PCNX1 as Predictors of Chemotherapy Response in Breast Cancer. Molecular Cancer Therapeutics. 19(3). 945–955. 14 indexed citations
4.
Dessauvagie, Benjamin F., Andrew H.S. Lee, Katie Meehan, et al.. (2018). Interobserver variation in the diagnosis of fibroepithelial lesions of the breast: a multicentre audit by digital pathology. Journal of Clinical Pathology. 71(8). 672–679. 19 indexed citations
5.
Levi, Dina, Vandna Shah, Cheryl Gillett, et al.. (2018). MED12, TERT promoter and RBM15 mutations in primary and recurrent phyllodes tumours. British Journal of Cancer. 118(2). 277–284. 28 indexed citations
6.
Avgustinova, Alexandra, Marjan Iravani, David Robertson, et al.. (2016). Tumour cell-derived Wnt7a recruits and activates fibroblasts to promote tumour aggressiveness. Nature Communications. 7(1). 10305–10305. 126 indexed citations
7.
Romańska, Hanna, Piotr Potemski, Radzisław Kordek, et al.. (2015). Lack of CD151/integrin α3β1 complex is predictive of poor outcome in node-negative lobular breast carcinoma: opposing roles of CD151 in invasive lobular and ductal breast cancers. British Journal of Cancer. 113(9). 1350–1357. 16 indexed citations
8.
Kim, Baek, Sam L. Stephen, Andrew M. Hanby, et al.. (2015). Chemotherapy induces Notch1-dependent MRP1 up-regulation, inhibition of which sensitizes breast cancer cells to chemotherapy. BMC Cancer. 15(1). 634–634. 52 indexed citations
9.
Rakha, Emad A., Sarah E. Pinder, John M.S. Bartlett, et al.. (2014). Updated UK Recommendations for HER2 assessment in breast cancer. Journal of Clinical Pathology. 68(2). 93–99. 194 indexed citations
10.
Lee, Alvin, Rebecca Roylance, Jil Sander, et al.. (2011). CERT depletion predicts chemotherapy benefit and mediates cytotoxic and polyploid‐specific cancer cell death through autophagy induction. The Journal of Pathology. 226(3). 482–494. 52 indexed citations
11.
Roylance, Rebecca, David Endesfelder, Patricia Gorman, et al.. (2011). Relationship of Extreme Chromosomal Instability with Long-term Survival in a Retrospective Analysis of Primary Breast Cancer. Cancer Epidemiology Biomarkers & Prevention. 20(10). 2183–2194. 133 indexed citations
12.
Burns, Philip A., Michele Cummings, Andrew M. Hanby, et al.. (2010). Estrogen Receptor β1 Expression Is Regulated by miR-92 in Breast Cancer. Cancer Research. 70(11). 4778–4784. 91 indexed citations
13.
Cummings, Michele, Mark Peter, Abeer M. Shaaban, et al.. (2008). Carcinoembryonic Antigen Cell Adhesion Molecule 6 Predicts Breast Cancer Recurrence following Adjuvant Tamoxifen. Clinical Cancer Research. 14(2). 405–411. 43 indexed citations
14.
Ringland, Clare, Adrienne Morey, Andrew M. Hanby, et al.. (2008). Poor-Prognosis Estrogen Receptor–Positive Breast Cancer Identified by Histopathologic Subclassification. Clinical Cancer Research. 14(20). 6625–6633. 10 indexed citations
15.
Simpson, Peter T., Jorge S. Reis‐Filho, Chris Jones, et al.. (2005). Columnar Cell Lesions of the Breast: The Missing Link in Breast Cancer Progression?. The American Journal of Surgical Pathology. 29(6). 734–746. 200 indexed citations
16.
Simpson, Peter T., Jorge S. Reis‐Filho, Chris Jones, et al.. (2005). Columnar cell lesions of the breast. The American Journal of Surgical Pathology. 29(6). 1 indexed citations
17.
Playford, Raymond J., Tania Marchbank, Rebecca Chinery, et al.. (1995). Human spasmolytic polypeptide is a cytoprotective agent that stimulates cell migration. Gastroenterology. 108(1). 108–116. 224 indexed citations
18.
Glover, Mary, et al.. (1995). Cutaneous Squamoproliferative Lesions in Renal Transplant Recipients. American Journal of Dermatopathology. 17(6). 551–554. 12 indexed citations
19.
Levison, David A., et al.. (1995). Nuclear and cytoplasmic bcl‐2 expression in endometrial hyperplasia and adenocarcinoma. The Journal of Pathology. 177(3). 241–246. 41 indexed citations
20.
Hanby, Andrew M., Richard Poulsom, Sukhdev Singh, et al.. (1993). Spasmolytic polypeptide is a major antral peptide: Distribution of the trefoil peptides human spasmolytic polypeptide and pS2 in the stomach. Gastroenterology. 105(4). 1110–1116. 150 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cheryl Gillett Breakdown of academic impact, for papers by José Palacios Breakdown of academic impact, for papers by James J. Going Breakdown of academic impact, for papers by Hans‐Peter Sinn Breakdown of academic impact, for papers by Tetsunari Oyama Breakdown of academic impact, for papers by Alan Mackay Breakdown of academic impact, for papers by Gamze Karaca Breakdown of academic impact, for papers by Shikha Bose Breakdown of academic impact, for papers by Rosemary R. Millis Breakdown of academic impact, for papers by Harry Hollema
Rankless by CCL
2026